Full Text
The Full Text of this article is available as a PDF (160.4 KB).
. 2001 Sep;52(Suppl 1):89S–96S. doi: 10.1046/j.1365-2125.2001.0520s1089.x
The role of therapeutic drug monitoring in treatment of HIV infection
David J Back
1, Saye H Khoo
1, Sara E Gibbons
1, Concepta Merry
2
David J Back
1Department of Pharmacology and Therapeutics, University of Liverpool, Ashton Street, Liverpool, L69 3GE, UK
Find articles by David J Back
Saye H Khoo
1Department of Pharmacology and Therapeutics, University of Liverpool, Ashton Street, Liverpool, L69 3GE, UK
Find articles by Saye H Khoo
Sara E Gibbons
1Department of Pharmacology and Therapeutics, University of Liverpool, Ashton Street, Liverpool, L69 3GE, UK
Find articles by Sara E Gibbons
Concepta Merry
2North-western University Medical School, Comprehensive AIDS Center, Chicago, Illinois 60611, USA
Find articles by Concepta Merry
1Department of Pharmacology and Therapeutics, University of Liverpool, Ashton Street, Liverpool, L69 3GE, UK
2North-western University Medical School, Comprehensive AIDS Center, Chicago, Illinois 60611, USA
✉
Correspondence: Professor D. J. Back, Department of Pharmacology and Therapeutics, University of Liverpool, Ashton Street, Liverpool L69 3GE, UK.
Keywords: inhibitory quotient, pharmacoenhancement, protease inhibitors, therapeutic drug monitoring
© 2001 Blackwell Science Ltd
PMCID: PMC2014620 PMID: 11564056